PhillipCapital Adjusts IX Biopharma’s Price Target to SG$0.25 From SG$0.355, Keeps at Buy
PhillipCapital Adjusts IX Biopharma’s Price Target to SG$0.25 From SG$0.355, Keeps at Buy
辉立资本将IX Biopharma的目标股价从0.355新加坡元调整至0.25新加坡元，维持买入
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册
资讯热榜
更新时间